載入...
Trial Watch: Peptide-based anticancer vaccines
Malignant cells express antigens that can be harnessed to elicit anticancer immune responses. One approach to achieve such goal consists in the administration of tumor-associated antigens (TAAs) or peptides thereof as recombinant proteins in the presence of adequate adjuvants. Throughout the past de...
Na minha lista:
| 發表在: | Oncoimmunology |
|---|---|
| Main Authors: | , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Taylor & Francis
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4485775/ https://ncbi.nlm.nih.gov/pubmed/26137405 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/2162402X.2014.974411 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|